THE STATUS ADVERSE REACTIONS AFTER PFIZER VACCINATION OF EMPLOYEES IN TAN TRAO UNIVERSITY IN 2021
DOI:
https://doi.org/10.51453/2354-1431/2022/869Keywords:
COVID-19, reaction after Pfizer vaccination.Abstract
The COVID-19 pandemic has caused of the deaths of millions of lives in the worldwide, and the number of deaths people continues to rise. Pfizer vaccine is being used widely for both adults and children in Vietnam. Therefore, we conducted a study: "The status adverse reactions after Pfizer vaccination of employees in Tan Trao University in 2021". After that, providing more evidence on the safety of COVID-19 vaccination for vaccine manufacturers as well as citizen, proposing recommendations in COVID-19 prevention in Tan Trao University. The retrospective study, conducted from November 2021 to January 2022 through interviews 123 employees who injected Pfizer vaccine, selected the entire sample using a available questionnaire. Results: 79.7% dose 1, 78.9% dose 2 had adverse reactions after Pfizer vaccination. Gender had a statistically significant relationship with reactions after Pfizer vaccination in both dose 1 and dose 2.
Downloads
References
References:
/[1]. Ministry of Health (2021), Decision No. 3695/QD-BYT on the addition of Article 1 of Decision No. 1654/QD-BYT dated March 23, 2021 of the Minister of Health on conditionally approving vaccines for urgent needs in the prevention and control of the COVID-19 epidemic, August 3, 2021.
/[2]. Ministry of Health (2021), Decision No. 2908/QD-BYT on conditional approval of Comirnaty vaccine for urgent needs in the period of COVID-19 disease prevention and control, June 12, 2021.
/[3]. National Institute of Hygiene and Epidemiology National Immunization Program (2021), Practical Manual on Immunization against COVID-19 (Pfizer-BioNtech's Comirnaty) (Training manual for health workers).
/[4]. How to classify and assess nutritional status based on Z-Score, at website: http://viendinhduong.vn/en/suy-dinh-duong-tre-em/cach-phan-loai-va-danh- gia-tinh-trang-dinh-duong-dua-vao-z-score-603.html, accessed October 24, 2021.
/[5]. Mohamed Adam (2021), Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia. Patient preference and adherence.
/[6]. Rikin Patel (2022). A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson, National Center for Biotechnology Information, 18(1): 2002083.
/[7]. Alejandro Pascual Iglesias (2021), An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era. US National Library of Medicine National Institutes of Health.
/[8]. Abanoub Riad (2021), Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. Journal of Clinical medicine.
/[9]. Seongman Bae (2021). Adverse Reactions following the first dose of ChAdOx1 nCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea, National Center for Biotechnology Information, 36(17): e115.
/[10]. Yun Woo Lee (2021). Adverse Reactions of the second dose of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in Korea, National Center for Biotechnology Information,36(21): e153.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All articles published in SJTTU are licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA) license. This means anyone is free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided they give appropriate attribution to the original author(s) and SJTTU, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to SJTTU to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
Although the conditions of the CC BY-SA license don't apply to authors (as the copyright holder of your article, you have no restrictions on your rights), by submitting to SJTTU, authors recognize the rights of readers, and must grant any third party the right to use their article to the extent provided by the license.
